26Serious

Martin Taylor

Ask VT AI

View News Summary

NFL pauses diversity program until 2026 to revamp and improve its effectiveness in increasing minority leadership roles.
Exelixis and Ensysce report strong biotech advances, with Exelixis' cancer drug Cabometyx driving revenue growth and Ensysce's opioid-use-disorder drug PF9001 showing promise.
Biden's health scrutinized again as a small nodule is found on his prostate during a routine exam, renewing concerns about his fitness to serve.

20 hours

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Ask VT AI

View News Summary

NFL pauses diversity program until 2026 to revamp and improve its effectiveness in increasing minority leadership roles.
Exelixis and Ensysce report strong biotech advances, with Exelixis' cancer drug Cabometyx driving revenue growth and Ensysce's opioid-use-disorder drug PF9001 showing promise.
Biden's health scrutinized again as a small nodule is found on his prostate during a routine exam, renewing concerns about his fitness to serve.

20 hours

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Most Reported By
News from Martin Taylor